From the Research
Inspire implantation for obstructive sleep apnea carries significant risks, including infection, temporary tongue weakness, and device malfunction, which patients should carefully consider before undergoing the procedure. The most common risks associated with Inspire implantation include:
- Infection at the implantation site, reported in 34.2% of cases 1
- Temporary tongue weakness or neuropraxia, occurring in 15.1% of cases 1
- Discomfort from the stimulation, with some patients experiencing pain around the incision sites
- Device malfunction, which may require additional surgery to repair or replace components, reported in 42.3% of adverse events 1
- Nerve damage, although rare, potentially causing prolonged numbness or weakness
- Risks associated with general anesthesia, including respiratory problems and adverse reactions
The procedure typically requires several weeks of recovery, during which patients may experience swelling, bruising, and difficulty swallowing. While serious complications are uncommon, patients should discuss their specific health conditions with their doctor to understand their individual risk profile before proceeding with Inspire implantation. It is essential to weigh these risks against the potential benefits of the therapy, which can improve quality of life for patients with obstructive sleep apnea who are intolerant to continuous positive airway pressure therapy 2.
Key considerations for patients undergoing Inspire implantation include:
- Understanding the potential risks and benefits of the procedure
- Discussing individual risk factors with their doctor
- Carefully following post-operative instructions to minimize complications
- Being aware of the potential need for additional surgery or device adjustments
- Considering alternative treatments, such as CPAP or mandibular advancement devices, if Inspire implantation is not suitable or effective.